Pulmonx (LUNG) Change in Account Payables (2019 - 2025)
Pulmonx (LUNG) posted quarterly Change in Account Payables of $121000.0 for Q3 2025, down 91.02% year-over-year from $1.3 million in Q3 2024, and down 94.35% quarter-over-quarter from $2.1 million in Q2 2025.
Pulmonx (LUNG) Change in Account Payables (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Change in Account Payables for 7 consecutive years, with $121000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Account Payables fell 91.02% year-over-year to $121000.0; the TTM figure through Sep 2025 stood at $2.1 million (up 61.41% YoY), while the FY2024 annual figure was $2.3 million, up 760.29% from the prior year.
- Change in Account Payables fell to $121000.0 in Q3 2025 per LUNG's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.6 million in Q3 2021 and bottomed at -$2.8 million in Q4 2021.
- Historically, Change in Account Payables has averaged $264894.7 across 5 years, with a median of $121000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Account Payables slumped 2111.11% — and 2025, when it jumped 42900.0%.
- Pulmonx's Change in Account Payables stood at -$2.8 million in 2021, then soared by 70.54% to -$830000.0 in 2022, then sank by 104.58% to -$1.7 million in 2023, then surged by 58.78% to -$700000.0 in 2024, then soared by 117.29% to $121000.0 in 2025.
- Business Quant data shows LUNG's Change in Account Payables at $121000.0 in Q3 2025, $2.1 million in Q2 2025, and $505000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 121,000.00 |
| Sep 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 505,000.00 |
| Mar 31, 2025 | 505,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Sep 30, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | -518,000.00 |
| Jun 30, 2023 | -518,000.00 |